MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Sinopsys Surgical gains $8.3M funding round for sinusitis device | Medtech funding for the week of October 20, 2014

Sinopsys Surgical gains $8.3M funding round for sinusitis device | Medtech funding for the week of October 20, 2014

By

Sinopsys Surgical sniffs up $8.3m for sinusitis device

October 17, 2014 by Alexander Soule

Sinopsys sniffs up $8.3m for sinusitis device

Stealth-mode startup Sinopsys Surgical said it raised $8.3 million in an equity funding round for the technique it’s developing to repurpose the tear duct to drain into the sinuses as a way to relieve chronic sinusitis.

CEO Dr. Harry Ross was a partner with Aweida Venture Partners of Superior, Colo., near to Sinopsys Surgical’s Boulder headquarters. Read more

ZipLine Medical adds $5.7m to Series C round

October 20, 2014 by Alexander Soule

ZipLine Medical adds $5.7m to Series C round

ZipLine Medical said it added a $5.7 million extension to its $4.3 million Series C round, with new investor China Materialia promising to help the company expand sales in the People’s Republic.

“This Series C extension allows us to further expand our sales and marketing activities to leverage the overwhelming support we are receiving from key opinion leaders among clinicians,” ZipLine CEO John Tighe said in prepared remarks. Read more

Medrobotics taps backers for $20m

October 21, 2014 by Alexander Soule

Medrobotics taps markets for $20m

Medrobotics said it closed on $20 million in new funding in a preferred stock sale to prior backers as plans to expand its commercial footprint in Europe.

Raynham, Mass.-based Medrobotics also said that it’s “met all applicable FDA requirements” to distribute its Flex Retractor in the U.S. Read more

Sensory Medical raises $1.4m for Relaxis restless legs treatment

October 21, 2014 by Alexander Soule

Sensory Medical raises $1.4m for restless-leg treatment

Sensory Medical shook a leg on a 2nd tranche of funding since receiving FDA clearance last spring for its device to relieve symptoms of restless legs syndrome, reporting $1.4 million in fresh funding on the heels of a $1 million tranche in June.

Restless leg syndrome is a neurological disorder that causes sensations giving people the urge to move and reposition their legs to relieve discomfort, disrupting their sleep. Scientists have yet to pin down the cause of RLS, but some suspect it is genetic in origin. Read more

Stealth hypertension startup Sympara Medical raises nearly $6m

October 23, 2014 by Alexander Soule

Stealth hypertension startup Sympara Medical raises nearly $6m

Stealthy Sympara Medical quietly secured $5.5 million in funding from a handful of investors for the hypertension device it’s developing.

San Francisco-based Sympara disclosed the funding in a regulatory filing, after recording $4.3 million with the SEC in 2013. Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • Steris plans to build a new medical device testing facility
    Steris (NYSE: STE) plans to build a new packaging and microbiological testing facility for medical devices in Leipzig, Germany. The facility will offer packaging testing services such as accelerated and real-time aging, transportation and integrity testing. The new location will also offer microbiological testing in collaboration with the medical device manufacturer and sterilizer’s laboratory in… […]
  • 10 medical device startups you need to know
    Some of the most interesting medical device startups of 2022 are advancing a wide range of innovative medtech: robotics, catheter-delivered brain-computer interfaces and more. The editors here at Medical Design & Outsourcing and MassDevice are writing about medical device startups all the time. But there are some device companies starting out that have technologies that… […]
  • Steris stock downgraded as analysts expect lawyers to seek more ethylene oxide lawsuits
    Steris (NYSE: STE) stock was downgraded today by Needham from buy to hold following the $363 million jury verdict against its primary competitor, Sterigenics, over ethylene oxide (EtO) emissions. Needham analysts said they expect attorneys to target communities near EtO facilities with ads to find people willing to file more lawsuits against sterilization plant operators… […]
  • Researchers develop at-home device to track Parkinson’s progression
    Researchers at MIT and the University of Rochester Medical Center have developed a device to monitor a Parkinson’s patient at home. Collecting data at home could help provide a less subjective measurement than evaluations at the doctor’s office, which can be affected by outside factors. The technology could also help pharmaceutical and biotech companies developing… […]
  • Micro Mold renovates for new 5-axis milling center
    Precision mold maker Micro Mold has renovated in Erie, Pennsylvania, to make room for its new Yasda YMC650 high-speed 5-axis milling center and 3R Workpartner automation cell. The new equipment will be used for electrode manufacturing and finishing hard mill applications. The milling machine is accurate to 1 micron for high-volume, ultra-precision tooling work, the… […]
  • September 2022 Issue: The Medtech Big 100 is bigger than ever
    Medtech sales reach a record high as R&D spend and employee counts climb Supply Chain EVP Greg Smith sees fewer suppliers in Medtronic’s future Autotransfusion device maker ships units to Ukraine How IP protection is enabling robotic surgery innovation Connected device design for the real world: Managing the development process FDA details plans to expand… […]
  • How NeuroOne and Zimmer Biomet will partner on robotic brain surgery
    NeuroOne (NASDAQ: NMTC) is preparing its depth electrode technology for commercialization through Zimmer Biomet (NYSE: ZBH) while waiting for FDA feedback on its latest submission. NeuroOne’s Evo stereoelectroencephalography (sEEG) device won FDA 510(k) clearance in September 2021 for recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain. That clearance was… […]
  • Trelleborg to show off advanced polymer tech at MD&M Minneapolis
    Trelleborg Healthcare & Medical will exhibit advanced polymer technologies for medical applications at MD&M Minneapolis, which runs Nov. 2–3, 2022. The Sweden-based engineering polymer giant, which has operations in 50 companies, has newly acquired, advanced capabilities in thermoplastic injection molding. The new injection molding capabilities come from its purchase of Menomonie, Wisconsin–based EirMed earlier this… […]
  • Millstone Medical Outsourcing expands cleanroom facility
    Millstone Medical Outsourcing said today that it has broken ground on a 5,000-square-foot cleanroom facility expansion at its Fall River, Massachusetts headquarters. The project is Millstone’s third cleanroom expansion. The additional Class 10,000/ISO7-rated cleanroom space is for medical device packaging operations. It will bring the company’s total cleanroom footprint to 20,000 square feet. Responding to… […]
  • Johnson & Johnson launches Bay Area science and technology campus
    Johnson & Johnson (NYSE:JNJ) has opened an almost 200,000 ft2 science and technology campus in the San Francisco Bay Area. The new facility more than doubles the presence of the company in the Bay Area, which has been a hub for life sciences innovation for decades. Up to 400 employees will work at the facility. “This… […]
  • VitalPath opens new Design Center in Minnesota
    VitalPath announced today that it recently opened a new Design Center in the Minneapolis suburb of New Hope. The Minnesota-based company manufactures custom, highly complex catheter solutions for major medical device companies. It says the new Design Center brings its entire design and prototyping capabilities under one roof in order to accelerate time to market.… […]

Leave a Reply